First of two parts

[1]  J. Sear,et al.  Myocardial Ischemia in Untreated Hypertensive Patients: Effect of a Single Small Oral Dose of a Beta‐Adrenergic Blocking Agent , 1988, Anesthesiology.

[2]  W. Daggett,et al.  Cardiovascular response to large doses of intravenous morphine in man. , 1969, The New England journal of medicine.

[3]  E. M. Papper,et al.  Pharmacologic and physiologic aspects of anesthesiology. , 1970, The New England journal of medicine.

[4]  S. Reiz,et al.  Isoflurane—A Powerful Coronary Vasodilator in Patients with Coronary Artery Disease , 1983, Anesthesiology.

[5]  M. Joyner,et al.  Blood Substitutes: Fluids, Drugs, or Miracle Solutions? , 1996, Anesthesia and analgesia.

[6]  Andrew D. Rosenberg,et al.  Practice Guidelines for Blood Component Therapy: A Report by the American Society of Anesthesiologists Task Force on Blood Component Therapy , 1996, Anesthesiology.

[7]  P. Duvaldestin,et al.  Intubating conditions following 1R CIS, 1′R CIS atracurium (51W89) , 1995, Anaesthesia.

[8]  H. H. Ali,et al.  Histamine-releasing potencies of atracurium, dimethyl tubocurarine and tubocurarine. , 1983, British journal of anaesthesia.

[9]  G. Gronert,et al.  Intractable cardiac arrest in children given succinylcholine. , 1992, Anesthesiology.

[10]  M. Sussman,et al.  Anesthesia-induced rhabdomyolysis in a patient with Duchenne's muscular dystrophy. , 1978, Anesthesiology.

[11]  B. Hindman,et al.  A Prospective, Comparative Trial of Three Anesthetics for Elective Supratentorial Craniotomy: Propofol/Fentanyl, Isoflurane/Nitrous Oxide, and Fentanyl/Nitrous Oxide , 1993, Anesthesiology.

[12]  L. Fleisher,et al.  Relationship between postoperative anemia and cardiac morbidity in high‐risk vascular patients in the intensive care unit , 1993, Critical care medicine.

[13]  D. Silverman,et al.  Intraoperative use of muscle relaxants , 1993 .

[14]  W. Bowman,et al.  Effects of a new neuromuscular blocking agent (Org 9426) in anaesthetized cats and pigs and in isolated nerve-muscle preparations. , 1989, British journal of anaesthesia.

[15]  D. Mangano.  Preoperative Risk Assessment: Many Studies, Few Solutions: Is a Cardiac Risk Assessment Paradigm Possible? , 1995, Anesthesiology.

[16]  S. Fischer,et al.  Development and Effectiveness of an Anesthesia Preoperative Evaluation Clinic in a Teaching Hospital , 1996, Anesthesiology.

[17]  P. Foëx,et al.  Studies of anaesthesia in relation to hypertension. I. Cardiovascular responses of treated and untreated patients. , 1971, British journal of anaesthesia.

[18]  T. Rao,et al.  Reinfarction Following Anesthesia in Patients with Myocardial Infarction , 1983, Anesthesiology.

[19]  S. Cotev,et al.  Importance of long-duration postoperative ST-segment depression in cardiac morbidity after vascular surgery , 1993, The Lancet.

[20]  A. Localio,et al.  A Clinical Grading Scale to Predict Malignant Hyperthermia Susceptibility , 1994, Anesthesiology.

[21]  J. Gross,et al.  Propofol Depresses the Hypoxic Ventilatory Response during Conscious Sedation and Isohypercapnia , 1993, Anesthesiology.

[22]  J. Hunter,et al.  Comparison of the pharmacodynamics and pharmacokinetics of an infusion of cis-atracurium (51W89) or atracurium in critically ill patients undergoing mechanical ventilation in an intensive therapy unit. , 1996, British journal of anaesthesia.

[23]  A. Muñoz,et al.  The declining risk of post-transfusion hepatitis C virus infection. , 1992, The New England journal of medicine.

[24]  R. Miller,et al.  Clinical Pharmacology of Vecuronium and Atracurium , 1984, Anesthesiology.

[25]  R. Prielipp,et al.  Prolonged weakness after infusion of atracurium in two intensive care unit patients. , 1994, Anesthesia and analgesia.

[26]  D. Silverman,et al.  Pulse Width, Stimulus Intensity, Electrode Placement, and Polarity during Assessment of Neuromuscular Block , 1995, Anesthesiology.

[27]  E. Eger,et al.  The Cardiovascular Effects of a New Inhalation Anesthetic, Forane, in Human Volunteers at Constant Arterial Carbon Dioxide Tension , 1971, Anesthesiology.

[28]  E. Eger,et al.  Toxicity of Compound A in Rats: Effect of a 3‐Hour Administration , 1994, Anesthesiology.

[29]  Shiv k. Sharma,et al.  A Comparison of 26-G Atraucan Spinal Needles with 25-G Whitacre Needles , 1994 .

[30]  E. Eger,et al.  Toxicity of Compound A in Rats: Effect of Increasing Duration of Administration , 1994, Anesthesiology.

[31]  M. Matthay,et al.  Persistent paralysis in critically ill patients after long-term administration of vecuronium. , 1992, The New England journal of medicine.

[32]  E. Eger,et al.  Polyhalogenated and perfluorinated compounds that disobey the Meyer-Overton hypothesis. , 1994, Anesthesia and analgesia.

[33]  T. Higgins,et al.  Propofol versus midazolam for intensive care unit sedation after coronary artery bypass grafting , 1994, Critical care medicine.

[34]  A. Levy,et al.  Value of routine preoperative chest x-rays: a meta-analysis , 1993, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[35]  Comparison of the pharmacodynamics and pharmacokinetics of an infusion of cis-atracurium (51W89) or atracurium in critically ill patients undergoing mechanical ventilation in an intensive therapy unit. , 1996 .

[36]  E. Delphin,et al.  Use of succinylcholine during elective pediatric anesthesia should be reevaluated. , 1987, Anesthesia and analgesia.

[37]  H. H. Ali,et al.  The Clinical Neuromuscular Pharmacology of Mivacurium Chloride (BW B1090U). A Short‐acting Nondepolarizing Ester Neuromuscular Blocking Drug , 1988, Anesthesiology.

[38]  Timothy M. Williams,et al.  Steal‐Prone Coronary Anatomy and Myocardial Ischemia Associated With Four Primary Anesthetic Agents in Humans , 1991, Anesthesia and analgesia.

[39]  E. Eger,et al.  Decreasing Enflurane Concentrations and d‐Tubocurarine Neuromuscular Blockade , 1982, Anesthesiology.

[40]  T. A. Bowdle.  Myoclonus following sufentanil without EEG seizure activity. , 1987, Anesthesiology.

[41]  J. Seltzer,et al.  Clinical Pharmacology of Pipecuronium Bromide , 1989, Anesthesia and analgesia.

[42]  G. Harrison.  Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium. , 1975, British journal of anaesthesia.

[43]  T. Ebert,et al.  Desflurane-mediated Neurocirculatory Activation in Humans: Effects of Concentration and Rate of Change on Responses , 1996, Anesthesiology.

[44]  J. McGill,et al.  Perioperative Management of Surgical Patients with Diabetes Mellitus , 1991, Anesthesiology.

[45]  D. R. Cook,et al.  In vitro degradation of atracurium in human plasma. , 1985, British journal of anaesthesia.

[46]  Ronald M. Jones,et al.  The organ toxicity of inhaled anesthetics. , 1995, Anesthesia and analgesia.

[47]  L. Fleisher,et al.  The predictive value of preoperative silent ischemia for postoperative ischemic cardiac events in vascular and nonvascular surgery patients. , 1991, American heart journal.

[48]  D. S. Savage,et al.  The Emergence of ORG NC 45, 1- [(2β,3α, 5α,16β, 17β)-3, 17-BIS(Acetyloxy)-2-(1-Piperidinyl)-Androstan-16-YL]-1-Methylpiperidinium Bromide, from the Pancuronium Series , 1980 .

[49]  J. Gold,et al.  Surveillance for postoperative myocardial infarction after noncardiac operations. , 1988, Surgery, gynecology & obstetrics.

[50]  D M Perrotta,et al.  Postoperative infections traced to contamination of an intravenous anesthetic, propofol. , 1995, The New England journal of medicine.

[51]  M. Wolff,et al.  Severe sepsis after intravenous injection of contaminated propofol. , 1994, Anesthesiology.

[52]  P. Sebel,et al.  Propofol: A New Intravenous Anesthetic , 1989, Anesthesiology.

[53]  Y. Ogasawara,et al.  Reaction of sevoflurane and its degradation products with soda lime. Toxicity of the byproducts. , 1992, Anesthesiology.

[54]  J. Hunter,et al.  Pharmacokinetics of 1R-cis 1'R-cis atracurium besylate (51W89) and plasma laudanosine concentrations in health and chronic renal failure. , 1995, British journal of anaesthesia.

[55]  G. A. Rooke,et al.  Postoperative myoclonus and rigidity after anesthesia with opioids. , 1994, Anesthesia and analgesia.

[56]  G. Koren,et al.  FENTANYL ANESTHESIA FOR CARDIAC SURGERY IN CHILDRENa) FENTANYL-OXYGEN VS FENTANYL-N2O; b) RELATIONSHIP BETWEEN DRUG CONCENTRATIONS AND PHARMACODYNAMICS , 1984 .

[57]  J. Divatia,et al.  Omission of Nitrous Oxide during Anesthesia Reduces the Incidence of Postoperative Nausea and Vomiting: A Meta-Analysis , 1996, Anesthesiology.

[58]  W. R. Lieb,et al.  Molecular and cellular mechanisms of general anaesthesia , 1994, Nature.

[59]  N. Goodman,et al.  Haemodynamic effects of infusions of diisopropyl phenol (ICI 35 868) during nitrous oxide anaesthesia in man. , 1983, British journal of anaesthesia.

[60]  E. Eger,et al.  Anesthetic potencies of sulfur hexafluoride, carbon tetrafluoride, chloroform and Ethrane in dogs: correlation with the hydrate and lipid theories of anesthetic action. , 1969, Anesthesiology.

[61]  A. J. Gandolfi,et al.  Adverse effects of volatile anaesthetics. , 1987, British journal of anaesthesia.

[62]  J. Janosky,et al.  Opioid Neurotoxicity: Neuropathologic Effects in Rats of Different Fentanyl Congeners and the Effects of Hexamethonium-Induced Normotension , 1996, Anesthesia and analgesia.

[63]  B. Chaitman,et al.  Preoperative clinical assessment and dipyridamole thallium-201 scintigraphy for prediction and prevention of cardiac events in patients having major noncardiovascular surgery and known or suspected coronary artery disease. , 1994, The American journal of cardiology.

[64]  R. Glavin,et al.  Comparison of midazolam with propofol for sedation in outpatient bronchoscopy. , 1993, British journal of anaesthesia.

[65]  J. Wierda,et al.  Clinical pharmacology of rocuronium (Org 9426): study of the time course of action, dose requirement, reversibility, and pharmacokinetics. , 1994, Journal of clinical anesthesia.

[66]  P. White,et al.  Propofol: An update on its Clinical Use , 1994, Anesthesiology.

[67]  G. Scheiber,et al.  Deep sedation with propofol in preschool children undergoing radiation therapy , 1996, Paediatric anaesthesia.

[68]  J. Hartung.  Twenty-Four of Twenty-Seven Studies Show a Greater Incidence of Emesis Associated with Nitrous Oxide than with Alternative Anesthetics , 1996, Anesthesia and analgesia.

[69]  L. Fleisher,et al.  Preoperative Dipyridamole Thallium Imaging and Ambulatory Electrocardiographic Monitoring as a Predictor of Perioperative Cardiac Events and Long‐term Outcome , 1995, Anesthesiology.

[70]  E. Eger,et al.  Decreasing Enflurane Concentrations and d-Tubocurarine Neuromuscular Blockade , 1982 .

[71]  D. Mangano,et al.  The risk of myocardial ischemia in patients receiving desflurane versus sufentanil anesthesia for coronary artery bypass graft surgery. The S.P.I. Research Group. , 1992, Anesthesiology.

[72]  A. Jaffe,et al.  Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I. , 1994, The New England journal of medicine.

[73]  M. Barrios,et al.  Comparative study of propofol versus midazolam in the sedation of critically ill patients: results of a prospective, randomized, multicenter trial. , 1996, Critical care medicine.

[74]  K. Davis,et al.  The Prevalence of Steal‐prone Coronary Anatomy in Patients with Coronary Artery Disease: An Analysis of the Coronary Artery Surgery Study Registry , 1988, Anesthesiology.

[75]  Eger Ei nd.  Desflurane animal and human pharmacology: aspects of kinetics, safety, and MAC. , 1992 .

[76]  N. Obuchowski,et al.  Intravenous sedation for MR imaging of the brain and spine in children: pentobarbital versus propofol. , 1993, Radiology.

[77]  Jeffery Vender,et al.  Comparison of the Infusion Requirements and Recovery Profiles of Vecuronium and Cisatracurium 51W89 in Intensive Care Unit Patients , 1995, Anesthesia and analgesia.

[78]  B. Thompson,et al.  Nuclear cardiac ejection fraction and cardiac index in abdominal aortic surgery. , 1983, Surgery.

[79]  A. J. Gandolfi,et al.  Plasma inorganic fluoride with sevoflurane anesthesia: correlation with indices of hepatic and renal function. , 1992 .

[80]  P. Suter,et al.  Adjuvant propofol enables better control of nausea and emesis secondary to chemotherapy for breast cancer , 1994, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[81]  F. Freund,et al.  Abdominal-muscle rigidity induced by morphine and nitrous oxide. , 1973, Anesthesiology.

[82]  F. Foldes,et al.  Succinylcholine: a new approach to muscular relaxation in anesthesiology. , 1952, The New England journal of medicine.

[83]  H. Van Aken,et al.  Remifentanil: A Novel, Short-Acting, mu-Opioid , 1996, Anesthesia and analgesia.

[84]  R. Hughes,et al.  The pharmacology of atracurium: a new competitive neuromuscular blocking agent. , 1981, British Journal of Anaesthesia.

[85]  R. P. Cochran,et al.  Perfluorocarbon emulsions and cardiopulmonary bypass: a technique for the future. , 1996, Journal of cardiothoracic and vascular anesthesia.

[86]  E. Keeler,et al.  RAND Corporation From the SelectedWorks of Emmett Keeler March , 1995 The Cost Effectiveness of Preoperative Autologous Blood Donations , 2016 .

[87]  W. Taylor,et al.  Myocardial infarction after general anesthesia. , 1973, Anesthesia and analgesia.